Data analysis

The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements

Retrieved on: 
Tuesday, April 9, 2024
Shenzhen University, Molecular biology, Immunology, Nature Methods, Advanced technology, Proteome, Ageing, Speech, Genesis (journal), Data analysis, Southern Medical University, Neuroscience, Translation, Human Cell Atlas, Nature Communications, Biochemistry, Neurology, Communication, Transcriptome, Genetics, Research, Genome, Epigenome, Immunity, Microbiology, Metabolome, Diagnosis, Peking University, Health, Conference, GSA, Executive, Cancer, Fudan University, Reproduction, Biology, National academy, Zhejiang University, Medicine

SHENZHEN, China, April 9, 2024 /PRNewswire/ -- The Second International Conference on Single-cell and Spatial Omics (TICSSO-2), was held from March 29th to April 1st, 2024, in Shenzhen, China.

Key Points: 
  • SHENZHEN, China, April 9, 2024 /PRNewswire/ -- The Second International Conference on Single-cell and Spatial Omics (TICSSO-2), was held from March 29th to April 1st, 2024, in Shenzhen, China.
  • With the theme "Technologic Innovation, Scientific Discovery, Translational Application", TICSSO-2 focused on the latest advances in single-cell and spatial omics.
  • On March 31st and April 1st were four online international forums, with one specifically for young researchers.
  • TICSSO-2 is hailed as the largest, most influential, and highest academic conference in the field of single-cell and spatial omics in the world.

IDTechEx Takes a Look at the Emerging Industrial Thermal Energy Storage Market

Retrieved on: 
Tuesday, April 9, 2024
Electricity, Players, Temperature, Conversation, CAES, Comprehensive, Growth, Heat, Data analysis, TES, Steam, Research, Silicon, LAES, Plant, Industrial, CO2, Kilowatt-hour, Atmosphere, Fossil, CSP, HTF, RTE, State, Thermal energy storage, Renewable energy

One such technology that is able to store and supply heat to industrial processes is thermal energy storage (TES).

Key Points: 
  • One such technology that is able to store and supply heat to industrial processes is thermal energy storage (TES).
  • From IDTechEx's new market report " Thermal Energy Storage 2024-2034: Technologies, Players, Markets, and Forecasts ", the industrial TES market will be valued at US$4.5B by 2034.
  • This could include sensible heat, latent heat, thermochemical energy storage (TCES), and electro-thermal / pumped thermal energy storage (ETES / PTES) technologies.
  • IDTechEx's market report appraises the various thermal energy storage technologies being developed and commercialized and analyzes their suitability for a range of applications.

IDTechEx Takes a Look at the Emerging Industrial Thermal Energy Storage Market

Retrieved on: 
Tuesday, April 9, 2024
Electricity, Players, Temperature, Conversation, CAES, Comprehensive, Growth, Heat, Data analysis, TES, Steam, Research, Silicon, LAES, Plant, Industrial, CO2, Kilowatt-hour, Atmosphere, Fossil, CSP, HTF, RTE, State, Thermal energy storage, Renewable energy

One such technology that is able to store and supply heat to industrial processes is thermal energy storage (TES).

Key Points: 
  • One such technology that is able to store and supply heat to industrial processes is thermal energy storage (TES).
  • From IDTechEx's new market report " Thermal Energy Storage 2024-2034: Technologies, Players, Markets, and Forecasts ", the industrial TES market will be valued at US$4.5B by 2034.
  • This could include sensible heat, latent heat, thermochemical energy storage (TCES), and electro-thermal / pumped thermal energy storage (ETES / PTES) technologies.
  • IDTechEx's market report appraises the various thermal energy storage technologies being developed and commercialized and analyzes their suitability for a range of applications.

Star Refrigeration helps Tesco to 10% energy savings across eight temperature controlled distribution sites

Retrieved on: 
Monday, April 8, 2024
Refrigeration, ROI, Longevity, Cold, Heat, Data analysis, Partnership, Global warming potential, Carbon, Marketing, CO2, Renewable energy, LZC, Consultant

LONDON, April 8, 2024 /PRNewswire-PRWeb/ -- Following a successful pilot program at three sites, Star Refrigeration and its strategic insights data monitoring system, Ethos, have helped the nation's largest retailer saved 4GWh on energy costs and over 835 tonnes of CO2e across its refrigerated distribution network.

Key Points: 
  • Star Refrigeration's Ethos AI delivers 4GWh in energy savings and an 835-tonne CO2e reduction for Tesco in 21 months, with an ROI of under three months.
  • This was a bold move which challenged conventional practises in the sector and helped Tesco to achieve substantial energy savings across its distribution network.
  • Rob Redfern, Tesco Group Energy Manager (Renewables & LZC), said, "As the UK's largest retailer, Tesco is committed to operating responsibly and sustainably.
  • To read the full case study on the Star Refrigeration and Tesco project and find out how Ethos achieved the savings, visit https://www.star-ref.co.uk/case-studies/tesco-saves-4gwh-of-energy-and-8...

Neon One Unveils "The Recurring Giving Report: Data-Backed Insights for Sustainable Generosity" - Empowering Nonprofits with the Blueprint for Sustainable Revenue

Retrieved on: 
Monday, April 8, 2024
IPH, Research, Longevity, Content, Data analysis, Management

CHICAGO, April 8, 2024 /PRNewswire/ -- Neon One, the nonprofit platform made for building communities of generosity, today unveils a significant research initiative: "The Recurring Giving Report: Data-Backed Insights for Sustainable Generosity".

Key Points: 
  • CHICAGO, April 8, 2024 /PRNewswire/ -- Neon One, the nonprofit platform made for building communities of generosity, today unveils a significant research initiative: "The Recurring Giving Report: Data-Backed Insights for Sustainable Generosity".
  • The Recurring Giving Report showcases Neon One's dedication to operational growth in the nonprofit sector.
  • Analyzing data from 100,000+ recurring donors, it offers practical strategies for enhancing fundraising through recurring gifts.
  • Key Insights from the Report:
    Unprecedented Growth: Analysis reveals a 144% increase in recurring revenue among studied nonprofits over five years, with the average nonprofit's recurring donor base expanding by 127%.

Findings Presented at ACC.24 Showed XARELTO® (rivaroxaban) Reduced the Risk of Clinically Significant Bleeding and Net Adverse Clinical Events or Rehospitalization

Retrieved on: 
Monday, April 8, 2024
Cardiology, Abstract, Harvard Medical School, Warfarin, NACE, Rivaroxaban, Ventricular fibrillation, Data analysis, Risk, Patient, Stroke, Research, CSB, American College, Clinical trial, PCI, Bleeding, Johnson & Johnson, Percutaneous coronary intervention, Pharmaceutical industry

NEW BRUNSWICK, N.J., April 8, 2024 /PRNewswire/ -- Johnson & Johnson announced today a new analysis of data from the PIONEER AF-PCI clinical trial demonstrating that XARELTO® (rivaroxaban) was associated with a reduced risk of clinically significant bleeding (CSB), and net adverse clinical events (NACE; a composite of clinically significant bleeding [CSB] or major adverse cardiovascular event [MACE]) or rehospitalization compared to warfarin among both elderly and non-elderly patients with nonvalvular atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), a nonsurgical procedure designed to relieve narrowing or occlusion of the coronary artery.1,2 These data were featured in an oral presentation today at the American College of Cardiology 73rd Annual Scientific Session & Expo (ACC.24) in Atlanta, Georgia (Abstract #906-04).

Key Points: 
  • "Despite advances in cardiovascular care, patients with nonvalvular AF continue to be at risk of potentially life-threatening cardiovascular events, especially older patients considered difficult to treat due to multiple factors, including age and co-morbidities," said C. Michael Gibson*, M.D., CEO, of the nonprofit Baim Institute and professor of Medicine, Harvard Medical School.
  • "A significant challenge in managing nonvalvular AF in older individuals undergoing PCI is determining a treatment that balances the prevention of stroke with the risk for bleeding.
  • Results from the PIONEER AF-PCI trial reinforce the need to continue to research this complex and fragile elderly patient population."
  • "With this new exploratory analysis at ACC.24, we're pleased to bring the latest research to healthcare providers that adds to the growing body of clinical evidence in older adults."

KBR Awarded over $450M in Systems Engineering, Acquisition, Research & Development and Operations Support Contracts

Retrieved on: 
Monday, April 8, 2024
Government, Unitary state, Data science, Data analysis, Intelligence, Research, Artificial intelligence, Acquisition, NSS, Architecture, Machine learning, Engineering, KBR, Renewable energy

HOUSTON, April 8, 2024 /PRNewswire/ -- KBR (NYSE: KBR) announced that it has been awarded new contracts estimated at more than $450 million to deliver highly technical systems engineering support and services to the U.S. Government.

Key Points: 
  • HOUSTON, April 8, 2024 /PRNewswire/ -- KBR (NYSE: KBR) announced that it has been awarded new contracts estimated at more than $450 million to deliver highly technical systems engineering support and services to the U.S. Government.
  • Under the terms of these contracts, KBR will provide systems engineering, acquisition support, phenomenology expertise and data science, as well as applied research, communications security infrastructure, operations and maintenance support.
  • These contracts focus on sustaining both space and ground systems, enhancing acquisition efficiency via digital engineering, [and?]
  • Additional focus items include providing architecting, engineering and analysis services to support delivery of enterprise capabilities and support to satellite operations.

rHEALTH's Publication in Nature Communications Highlights Its Powerful Lab Diagnostics for Astronauts

Retrieved on: 
Friday, April 5, 2024
Flow cytometry, Technology readiness level, Environment, Data analysis, Partnership, Laser, International Space Station, Transport, Johnson Space Center, NASA, ISS, ONE, Artifact, Nature Communications, Medical device

BEDFORD, Mass., April 5, 2024 /PRNewswire-PRWeb/ -- rHEALTH today announced that, in partnership with NASA, that its study of the rHEALTH ONE universal biomedical analyzer on the International Space Station (ISS), was published in Nature Communications. The article, titled, "Single Drop Cytometry Onboard the International Space Station" performs detailed analysis of the data collected by the rHEALTH ONE device.

Key Points: 
  • The publication shows sophisticated laboratory diagnostics can be implemented successfully in environments previously thought to be too unforgiving and challenging.
  • Astronauts traveling to the Moon and Mars require immediate health information, just like all of us on Earth.
  • The study supports the ability to perform real-time lab analysis for astronauts in a microgravity environment, paving the way for human missions to the Moon and Mars.
  • This study further supports our mission to bring more powerful diagnostics outside conventional hospital settings," said Eugene Chan MD, Founder and CEO of rHEALTH.

FocalPoint Holdings and CodexIT Join Forces to Acquire Conclusn, Building a Best-in-Class Healthcare Analytics Dashboard System

Retrieved on: 
Friday, April 5, 2024
Growth, Acquisition, Entrepreneurship, Data analysis, Nursing

COLUMBUS, Ohio, April 5, 2024 /PRNewswire-PRWeb/ -- FocalPoint Holdings, a leader in healthcare software development, and CodexIT, a provider of healthcare technology solutions and professional services, today announced a joint venture to acquire Conclusn, a rapidly growing healthcare analytics company. This strategic acquisition combines FocalPoint's development team with CodexIT's technical services team, along with both of their long-term healthcare industry expertise. The newly formed entity will leverage Conclusn's existing platform to create one of the most powerful and user-friendly analytics dashboards available to healthcare practices as both a standalone platform and as an integrated module for FocalPoint's Promptly Patient Experience suite software.

Key Points: 
  • FocalPoint Holdings, a leader in healthcare software development, and CodexIT, a provider of healthcare technology solutions and professional services, today announced a joint venture to acquire Conclusn, a rapidly growing healthcare analytics company.
  • COLUMBUS, Ohio, April 5, 2024 /PRNewswire-PRWeb/ -- FocalPoint Holdings, a leader in healthcare software development, and CodexIT, a provider of healthcare technology solutions and professional services, today announced a joint venture to acquire Conclusn, a rapidly growing healthcare analytics company.
  • "We are thrilled to join forces with CodexIT and Conclusn," said Anish Kapur, CEO of FocalPoint Holdings.
  • "By combining our strengths, we can create a best-in-class analytics solution for healthcare groups," said Wes Strickling, CEO of CodexIT.

Global Mofy Metaverse Explores Partnership to Integrate Metaverse and AI Technology with Traditional Chinese and Western Therapeutic Practices

Retrieved on: 
Monday, March 25, 2024
Learning, Data analysis, Partnership, Education, Patient, Research, AI, Investment, Virtual reality, GMM

The goal is to combine Metaverse and AI technologies with traditional Chinese and Western healing methods.

Key Points: 
  • The goal is to combine Metaverse and AI technologies with traditional Chinese and Western healing methods.
  • During the initial meeting, the team outlined a strategic approach focused on developing a system for training and education using virtual reality.
  • Mr. Haogang Yang, CEO of Global Mofy Metaverse, stated, “We are thrilled to engage in discussions with such a distinguished and respected expert in the medical field.
  • We anticipate that in the near future, the integration of Metaverse and AI technologies will become commonplace across the healthcare industry.